EBookClubs

Read Books & Download eBooks Full Online

EBookClubs

Read Books & Download eBooks Full Online

Book The Cost Effectiveness of Prostate Cancer Screening   PSA Testing

Download or read book The Cost Effectiveness of Prostate Cancer Screening PSA Testing written by Justo Méndez and published by . This book was released on 2006 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Costs and Effectiveness of Prostate Cancer Screening in Elderly Men

Download or read book Costs and Effectiveness of Prostate Cancer Screening in Elderly Men written by DIANE Publishing Company and published by DIANE Publishing. This book was released on 1998 with total page 141 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Costs and Effectiveness of Prostate Cancer Screening in Elderly Men

Download or read book Costs and Effectiveness of Prostate Cancer Screening in Elderly Men written by United States. Congress. Office of Technology Assessment and published by U.S. Government Printing Office. This book was released on 1995 with total page 162 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Costs and effectiveness of prostate cancer screening in elderly men

Download or read book Costs and effectiveness of prostate cancer screening in elderly men written by and published by DIANE Publishing. This book was released on with total page 134 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Cost comparison of Prostate Cancer Screening Versus Not Screening

Download or read book Cost comparison of Prostate Cancer Screening Versus Not Screening written by Bill Fell and published by . This book was released on 2006 with total page 122 pages. Available in PDF, EPUB and Kindle. Book excerpt: Prostate cancer is a common form of cancer in men. In fact, prostate cancer has the highest incidence of any cancer in men. Prostate cancer is not only common, it carries a significant financial burden. The cost of prostate cancer is 11.3% of all cancer expenditures. If after a DRE the prostate is enlarged, or if the PSA is elevated, then a biopsy of the prostate would be recommended. Under the best of circumstances, cancer diagnoses will be missed and many will undergo unnecessary biopsy, etc. The focus of this paper was the cost-utility of screening with the PSA test. The cost differences between screening and not screening was compared. A Markov analysis and a Monte Carlo simulation were utilized to provide a basis for conclusion. The primary finding is that the costs associated with screening are much higher than those of not screening. Additional findings are that the specificity of the PSA test, the first year treatment costs, and the utility/outcomes of screening have an impact on the cost-utility of screening. The conclusion, however, is that the improvements in these factors would have to be significant to impact the case for screening. Until longitudinal studies are completed, it is not cost-effective to screen for prostate cancer.

Book The Great Prostate Hoax

Download or read book The Great Prostate Hoax written by Richard J. Ablin and published by Macmillan. This book was released on 2014-03-04 with total page 274 pages. Available in PDF, EPUB and Kindle. Book excerpt: Reveals how fear-based and inaccurate testing is resulting in unnecessary high-risk surgeries, arguing that the PSA test was never intended for prostate cancer screening.

Book Costs and Effectiveness of Prostate Cancer in Screening in Elderly Men

Download or read book Costs and Effectiveness of Prostate Cancer in Screening in Elderly Men written by and published by . This book was released on 1995 with total page 130 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, the prostate cancer diagnosis rate has increased dramatically, with a slower increase in age-specific mortality. At least in part, the increasing incidence undoubtedly reflects more aggressive efforts at early detection of prostate cancer, particularly through the use of a new blood test, prostate-specific antigen (PSA). This background paper examines the implications of a potential Medicare benefit to cover prostate cancer screening using a combination of the PSA and digital rectal examination (DRE), a time-honored test performed in the physician's office. OTA concludes that the evidence of benefit for prostate cancer screening is substantially weaker than for preventive services already covered by Medicare. Because the scientific knowledge is limited, but the consequences of prostate cancer and its treatment are serious, an informed patient and his physician could equally well decide to receive screening or forgo it. Medicare reimbursement could be one means of insuring that out-of-pocket expenses not impede well-informed decision-making between physician and patient about whether to receive screening.

Book Adenocarcinoma of the Prostate

Download or read book Adenocarcinoma of the Prostate written by Andrew W. Bruce and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 363 pages. Available in PDF, EPUB and Kindle. Book excerpt: Carcinoma of the prostate increasingly dominates the attention of urologists for both scientific and clinical reasons. The search for an explanation and the prediction of the variable behaviour of the malignant prostatic cell continues unabated. The search for more precise tumour staging and more effective treatment is equally vigorous. Editors Andrew Bruce and John Trachtenberg have assembled acknowledged leaders in prostate cancer to present those areas of direct interest to the clinician. There are a number of other topics that might have been considered but most of these, such as experimental tumour models or biochemical factors affecting cell growth, still lack immediate application for the clinician. Carcinoma of the prostate continues to have its highest incidence in the western world, and the difference in comparison with the incidence in the Far East appears to be real and not masked by diagnostic or other factors. A number of other epidemiological aspects need careful analysis: Is the incidence increasing? Is the survival improving? Is the prognosis worse in the younger patient? Epidemiological data are easily misused and misinterpreted so that a precise analysis of the known facts makes an important opening chapter to this book.

Book A Cost benefit Analysis of PSA based Prostate Cancer Screening

Download or read book A Cost benefit Analysis of PSA based Prostate Cancer Screening written by Nadezhda Ivanovna Lomakina and published by . This book was released on 2014 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book A Cost benefit Analysis of PSA based Prostate Cancer Screening

Download or read book A Cost benefit Analysis of PSA based Prostate Cancer Screening written by and published by . This book was released on 2014 with total page 74 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Book Time Driven Activity Based Costing

Download or read book Time Driven Activity Based Costing written by Robert S. Kaplan and published by Harvard Business Press. This book was released on 2007-02-22 with total page 283 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the classroom, ABC looks like a great way to manage a company’s resources. But many executives who have tried to implement ABC on a large scale in their organizations have found the approach limiting and frustrating. Why? The employee surveys that companies used to estimate resources required for business activities proved too time-consuming, expensive, and irritating to employees. This book shows you how to implement time-driven activity-based costing (TDABC), an easier and more powerful way to implement ABC. You can now estimate directly the resource demands imposed by each business transaction, product, or customer. The payoff? You spend less time and money obtaining and maintaining TDABC data—and more time addressing problems that TDABC reveals, such as inefficient processes, unprofitable products and customers, and excess capacity. The authors also show how to use TDABC to link strategic planning to operational budgeting, to enhance the due diligence process for mergers and acquisitions, and to support continuous improvement activities such as lean management and benchmarking. In presenting their model, the authors define the two questions required to build TDABC: 1) How much does it cost per time unit to supply resource capacity for each business process? 2) How much resource capacity (time) is required to perform work for a company’s many transactions, products, and customers? The book demonstrates how to develop simple, valid answers to these two questions. Kaplan and Anderson illustrate the TDABC approach with a wealth of case studies, in diverse settings, based on actual implementations.

Book A Micro Simulation Model of the Benefits and Costs of Prostate Cancer Screening and Treatment

Download or read book A Micro Simulation Model of the Benefits and Costs of Prostate Cancer Screening and Treatment written by and published by . This book was released on 2002 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This idea development award developed a micro-simulation model of prostate cancer screening and treatment. As described in our initial proposal, we developed an detailed model of the natural history, screening, and treatment of prostate cancer organized around a Markov model that incorporated true stage and grade of tumor, misclassification of tumors that generates discrepancies between clinical and true stage, and other innovative features that had been neglected in prior models. We also extended the model to account for persistent heterogeneity that would not be adequately modeled by usual Markov models. We also did a detailed structured literature review to estimate key parameters of our model and developed new techniques to estimate the parameters of the natural history model by fitting it to aggregate and individual-level data from the SEER program. Our baseline analysis suggests that screening and treatment will increase life expectancy but decrease quality-adjusted life expectancy. Potential gains are largest in men ages SO-70 and when undiagnosed cancer creates substantial anxiety. We published a paper based on some initial analyses of treatment patterns, have a main cost-effectiveness manuscript in progress, and received ROl funding from the National Cancer Institute to further extend this work.

Book Testing Treatments

Download or read book Testing Treatments written by Imogen Evans and published by Pinter & Martin Publishers. This book was released on 2011 with total page 187 pages. Available in PDF, EPUB and Kindle. Book excerpt: This work provides a thought-provoking account of how medical treatments can be tested with unbiased or 'fair' trials and explains how patients can work with doctors to achieve this vital goal. It spans the gamut of therapy from mastectomy to thalidomide and explores a vast range of case studies.

Book Economic Evaluation in Clinical Trials

Download or read book Economic Evaluation in Clinical Trials written by Henry A. Glick and published by Handbooks in Health Economic E. This book was released on 2014-10-02 with total page 265 pages. Available in PDF, EPUB and Kindle. Book excerpt: It is increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. This book provides a practical guide to the techniques and issues involved in conducting economic evaluation in ongoing clinical trials, supported with examples.

Book Clinical Oncology

    Book Details:
  • Author : Martin D. Abeloff
  • Publisher :
  • Release : 2000
  • ISBN : 9780443075452
  • Pages : 0 pages

Download or read book Clinical Oncology written by Martin D. Abeloff and published by . This book was released on 2000 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: A must-have reference, this new edition provides practical information on treatment guidelines, details of diagnosis and therapy, and personal recommendations on patient management from experts in the field. Consistently formatted chapters allow for a user-friendly presentation for quick access of key information by the practicing clinician. Completely updated, this new edition includes all of the latest developments in treatment strategies of medical, surgical and radiation oncologists.

Book Fulfilling the Potential of Cancer Prevention and Early Detection

Download or read book Fulfilling the Potential of Cancer Prevention and Early Detection written by National Research Council and published by National Academies Press. This book was released on 2003-05-07 with total page 564 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cancer ranks second only to heart disease as a leading cause of death in the United States, making it a tremendous burden in years of life lost, patient suffering, and economic costs. Fulfilling the Potential for Cancer Prevention and Early Detection reviews the proof that we can dramatically reduce cancer rates. The National Cancer Policy Board, part of the Institute of Medicine, outlines a national strategy to realize the promise of cancer prevention and early detection, including specific and wide-ranging recommendations. Offering a wealth of information and directly addressing major controversies, the book includes: A detailed look at how significantly cancer could be reduced through lifestyle changes, evaluating approaches used to alter eating, smoking, and exercise habits. An analysis of the intuitive notion that screening for cancer leads to improved health outcomes, including a discussion of screening methods, potential risks, and current recommendations. An examination of cancer prevention and control opportunities in primary health care delivery settings, including a review of interventions aimed at improving provider performance. Reviews of professional education and training programs, research trends and opportunities, and federal programs that support cancer prevention and early detection. This in-depth volume will be of interest to policy analysts, cancer and public health specialists, health care administrators and providers, researchers, insurers, medical journalists, and patient advocates.